491
491
Dec 17, 2012
12/12
by
CNNW
tv
eye 491
favorite 0
quote 0
the usual, bob? not today. [ male announcer ] bob has afib: atrial fibrillation not caused by a heart valve problem, a condition that puts him at greater risk for a stroke. [ gps ] turn left. i don't think so. [ male announcer ] for years, bob took warfarin, and made a monthly trip to the clinic to get his blood tested. but not anymore. bob's doctor recommended a different option: once-a-day xarelto®. xarelto® is the first and only once-a-day prescription blood thinner for patients with afib not caused by a heart valve problem, that doesn't require routine blood monitoring. like warfarin, xarelto® is proven effective to reduce the risk of an afib-related stroke. there is limited data on how these drugs compare when warfarin is well managed. no routine blood monitoring means bob can spend his extra time however he likes. new zealand! xarelto® is just one pill a day, taken with the evening meal. and with no dietary restrictions, bob can eat the healthy foods he likes. do not stop taking xarelto® r
the usual, bob? not today. [ male announcer ] bob has afib: atrial fibrillation not caused by a heart valve problem, a condition that puts him at greater risk for a stroke. [ gps ] turn left. i don't think so. [ male announcer ] for years, bob took warfarin, and made a monthly trip to the clinic to get his blood tested. but not anymore. bob's doctor recommended a different option: once-a-day xarelto®. xarelto® is the first and only once-a-day prescription blood thinner for patients with afib...
209
209
Dec 17, 2012
12/12
by
CNBC
tv
eye 209
favorite 0
quote 0
and bob, where has the money flow been? are you having any expectations of where the leadership in this market is in 2013? is this the same group, sam? >> no. i think what we're seeing first off is a muted v-shape recovery. where the bottom's occurring arounded the globe by the end of this year, first quarter of next. our belief is that we're likely to see growth by the industrials which traditionally or at least in the recent past have been underperformers. but have held up well during the most recent selloff. we still like consumer discretionary. they're getting pricey, but we think there's good stek kals behind them. and our belief is that here good growth, major pharmaceuticals likely to be improving their drug pipelines in the years ahead. and so in a sense you go cyclical as you enter into '13. >> the industrial move up is on the china has bottomed play. which is very, very prevalent and very popular right now. it's still kind of -- the jury is still out, but they're definitely buying recently in china. elsewhere you
and bob, where has the money flow been? are you having any expectations of where the leadership in this market is in 2013? is this the same group, sam? >> no. i think what we're seeing first off is a muted v-shape recovery. where the bottom's occurring arounded the globe by the end of this year, first quarter of next. our belief is that we're likely to see growth by the industrials which traditionally or at least in the recent past have been underperformers. but have held up well during...
100
100
Dec 17, 2012
12/12
by
CNBC
tv
eye 100
favorite 0
quote 0
rbc says that's a good sign for the stock. >> and give a shout out to our friend, bob. what is he doing with this? usg. >> another rbc call. bob wp good for this show. raising usg to 35 bucks and putting this in his firm's top pick groups. sees 10% jump in board sales. home improvement trends tend to get bet are. they will make more money on each wall board. >> i cannot get through each day without at least six cups of coffee, which is good for a company like there, caribou. >> i have to say it is my favorite coffee. but they are gone now. because privately held german company is buying caribou. interestingly enough, they coupled and bought peet's coffee. they are becoming a german starbucks competitor. if you own caribou off toy stib this morning, congratulations. cutting price target to 675 to 575, this is despite report that apple sold more than 2 million iphone 5s in three days in china. remember all of the lines, everybody freaked out. didn't matter. they had lottery ticket. still sold iphones in china eye poen is 51% of apple's total revenue. you cannot understate
rbc says that's a good sign for the stock. >> and give a shout out to our friend, bob. what is he doing with this? usg. >> another rbc call. bob wp good for this show. raising usg to 35 bucks and putting this in his firm's top pick groups. sees 10% jump in board sales. home improvement trends tend to get bet are. they will make more money on each wall board. >> i cannot get through each day without at least six cups of coffee, which is good for a company like there, caribou....
617
617
Dec 17, 2012
12/12
by
KGO
tv
eye 617
favorite 0
quote 0
the usual, bob? not today. [ male announcer ] bob has afib: atrial fibrillation not caused by a heart valve problem, a condition that puts him at greater risk for a stroke. [ gps ] turn left. i don't think so. [ male announcer ] for years, bob took warfarin, and made a monthly trip to the clinic to get his blood tested. but not anymore. bob's doctor recommended a different option: once-a-day xarelto®. xarelto® is the first and only once-a-day prescription blood thinner for patients with afib not caused by a heart valve problem, that doesn't require routine blood monitoring. like warfarin, xarelto® is proven effective to reduce the risk of an afib-related stroke. there is limited data on how these drugs compare when warfarin is well managed. no routine blood monitoring means bob can spend his extra time however he likes. new zealand! xarelto® is just one pill a day, taken with the evening meal. and with no dietary restrictions, bob can eat the healthy foods he likes. do not stop taking xarelto® r
the usual, bob? not today. [ male announcer ] bob has afib: atrial fibrillation not caused by a heart valve problem, a condition that puts him at greater risk for a stroke. [ gps ] turn left. i don't think so. [ male announcer ] for years, bob took warfarin, and made a monthly trip to the clinic to get his blood tested. but not anymore. bob's doctor recommended a different option: once-a-day xarelto®. xarelto® is the first and only once-a-day prescription blood thinner for patients with afib...
214
214
Dec 17, 2012
12/12
by
CNBC
tv
eye 214
favorite 0
quote 0
our guest host for the hour is bob doll. and bob, i was just looking through the "usa today" money section. you're on the cover of it. >> i see. >> in the investment roundtable section. it says here that the biggest issue, biggest deciding factor for how the next year is in terms of market is going to be washington? >> politics is the biggest risk. absent that risk there's some good things happening. but that risk can trump everything if they make the wrong move back to an earlier conversation. >> we speak with michelle meyer in the last hour and she's really concerned that no matter what happens, because you're going to see some sort of a deal it's going to mean some austerity. that very likely is going to cut into the consumer. if you don't have the businesses stepping back up in terms of investment is that going to be the vicious cycle that kind of kicks in? >> yeah, we need corporations to step up back to this uncertainty. if we get a little less unstirn, some of that cash needs to be put to work. consumers aren't going
our guest host for the hour is bob doll. and bob, i was just looking through the "usa today" money section. you're on the cover of it. >> i see. >> in the investment roundtable section. it says here that the biggest issue, biggest deciding factor for how the next year is in terms of market is going to be washington? >> politics is the biggest risk. absent that risk there's some good things happening. but that risk can trump everything if they make the wrong move back...
233
233
Dec 17, 2012
12/12
by
CNBC
tv
eye 233
favorite 0
quote 0
some other numbers on wednesday. >> bob, thanks a lot. bob pisani. kayla tausche has the market flash. >> carl, we've been back and forth about whether the reception of the iphone 5 in china is going to be good or bad. some checks on friday said it was muted. that led suppliers down. we're seeing them see some relief from that pressure. today may be a correction from that downtrade on friday. qualcomm one of the best trades today, also skyworks solutions. also favorable moves for avago and cirrus logic. >> the likes of fedex, oracle and rim reporting results. what do you need to know before the results come out? let's bring in christine short, senior managing of s&p capital iq. >> great to see you, thank you. >> what's amazing is the -- how the expectations for income or earnings have come down just since october 1st, right? >> right. and you're right. they've completely cratered. if you recall back during the third quarter earnings season, when we entered the season, we were seeing third quarter estimates were negative. we were looking at fourth qua
some other numbers on wednesday. >> bob, thanks a lot. bob pisani. kayla tausche has the market flash. >> carl, we've been back and forth about whether the reception of the iphone 5 in china is going to be good or bad. some checks on friday said it was muted. that led suppliers down. we're seeing them see some relief from that pressure. today may be a correction from that downtrade on friday. qualcomm one of the best trades today, also skyworks solutions. also favorable moves for...
762
762
Dec 17, 2012
12/12
by
WRC
tv
eye 762
favorite 0
quote 0
the usual, bob? not today. [ male announcer ] bob has afib: atrial fibrillation not caused by a heart valve problem, a condition that puts him at greater risk for a stroke. [ gps ] turn left. i don't think so. [ male announcer ] for years, bob took warfarin, and made a monthly trip to the clinic to get his blood tested. but not anymore. bob's doctor recommended a different option: once-a-day xarelto®. xarelto® is the first and only once-a-day prescription blood thinner for patients with afib not caused by a heart valve problem, that doesn't require routine blood monitoring. like warfarin, xarelto® is proven effective to reduce the risk of an afib-related stroke. there is limited data on how these drugs compare when warfarin is well managed. no routine blood monitoring means bob can spend his extra time however he likes. new zealand! xarelto® is just one pill a day, taken with the evening meal. and with no dietary restrictions, bob can eat the healthy foods he likes. do not stop taking xarelto® r
the usual, bob? not today. [ male announcer ] bob has afib: atrial fibrillation not caused by a heart valve problem, a condition that puts him at greater risk for a stroke. [ gps ] turn left. i don't think so. [ male announcer ] for years, bob took warfarin, and made a monthly trip to the clinic to get his blood tested. but not anymore. bob's doctor recommended a different option: once-a-day xarelto®. xarelto® is the first and only once-a-day prescription blood thinner for patients with afib...